Characterization of TNP-470-induced modifications to cell functions in HUVEC and cancer cells

Journal of Pharmacological and Toxicological Methods

Volumn 43, Issue 1, 2000, Pages 15-24

  Farinelle, Sophie ^a   Malonne, Hugues ^a   Chaboteaux, Carole ^a   Decaestecker, Christine ^a,c   Dedecker, Robert ^a   Gras, Thierry ^a   Darro, Francis ^a   Fontaine, Jeanine ^a   Atassi, Ghanem ^b   Kiss, Robert ^a,c  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^c FNRS   (Belgium)

Author keywords

Angiogenesis; Cell growth; Cell motility; HUVEC cell line; Mouse mammary MXT adenocarcinoma; TNP 470

Indexed keywords

FUMAGILLOL CHLOROACETYLCARBAMATE; MATRIGEL;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL FUNCTION; CELL GROWTH; CELL MIGRATION; CELL MOTILITY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION;

ADENOCARCINOMA; ANGIOGENESIS INHIBITORS; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BIOCOMPATIBLE MATERIALS; CELL DIVISION; CELL MOVEMENT; COLLAGEN; COLONIC NEOPLASMS; CYCLOHEXANES; DRUG COMBINATIONS; ENDOTHELIUM, VASCULAR; GLIOBLASTOMA; GROWTH INHIBITORS; HUMANS; LAMININ; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PACLITAXEL; PROTEOGLYCANS; SESQUITERPENES; TUMOR CELLS, CULTURED;

EID: 0033711746     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8719(00)00080-0     Document Type: Article

References (33)

1. A fumagillin derivative angiogenesis inhibitor, AGM-1470, inhibits activation of cyclin-dependent kinases and phosphorylation of retinoblastoma gene product but not protein tyrosyl phosphorylation or protooncogene expression in vascular endothelial cells
2. Regression of metastatic liver tumors in rats treated with angiogenesis inhibitor TNP-470: Occurrence of apoptosis and necrosis
3. In vitro and in vivo stimulation of the murine immune system by AGM-1470, a potent angiogenesis inhibitor
4. AGM-1470, a potent angiogenesis inhibitor, prevents the entry of normal but not transformed endothelial cells into the G1 phase of the cell cycle
5. The microtubule-affecting drug paclitaxel has antiangiogenic activity
6. The effect of the anti-angiogenic agent TNP-470 on tumor growth and vascularity in low passaged xenografts of human gliomas in nude mice
7. Influence of gastrin on human astrocytic tumor cell proliferation
8. Morphology of MXT mouse mammary tumors. Correlation with growth characteristics and hormone sensitivity
9. Gastrin inhibits motility, decreases cell death and increases cell proliferation in human glioblastoma cell lines
10. In vitro motility evaluation of aggregated cancer cells by means of automatic image processing
11. Setting up of an original computer-assisted methodology to characterize in vitro drug-induced anti-angiogenic effects
12. Clinical applications of research on angiogenesis
13. Human vascular endothelial cells in culture: Growth and DNA synthesis
14. Therapeutic efficacy of the angiogenesis inhibitor O-(chloroacetyl-carbamoyl) fumagillol (TNP-470, AGM-1470) for human anaplastic thyroid carcinoma in nude mice
15. Paclitaxel/carboplatin administration along with antiangiogenic therapy in non-small-cell lung and breast carcinoma models
16. Suppression of cylin D1 mRNA expression by the angiogenesis inhibitor TNP-470 (AGM-1470) in vascular endothelial cells
17. Increased growth and incidence of lymph node metastases due to the angiogenesis inhibitor AGM-1470
18. Effect of angiogenesis inhibitor TNP-470 on the progression of human gastric cancer xenotransplanted into nude mice
19. Inhibitory effects of the antiangiogenic agent TNP-470 on establishment and growth of hematogenous metastasis of human pancreatic carcinoma in SCID beige mice in vivo
20. Influence of pituitary grafts or prolactin administrations on the hormone sensitivity of ovarian hormone-independent mouse mammary MXT tumors
21. Complete remission of metastatic cervical cancer with the angiogenesis inhibitor TNP-470
22. Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470)
23. Inhibition of lymph node metastasis by an anti-antiogenic agent, TNP-470
24. Antiangiogenic therapy of transgenic mice impairs de novo tumor growth
25. Angiogenesis inhibitor TNP-470 inhibits human breast cancer osteolytic bone metastasis in nude mice through the reduction of bone resorption
26. Inhibition of tumor growth and metastasis by angiogenesis inhibitor TNP-470 on breast cancer cell lines in vitro and in vivo
27. Angiogenesis inhibitor TNP-470 suppresses tumorigenesis in rat urinary bladder
28. Clinical trials of antiangiogenic agents
29. Effects of an anti-angiogenic agent, TNP-470, on the growth of oral squamous cell carcinomas
30. Angiostatic treatment of neuroblastoma
31. Inhibition of angiogenesis induces chromaffin differentiation and apoptosis in neuroblastoma
32. The angiogenesis inhibitor TNP-470 reduces the growth rate of human neuroblastoma in nude rats
33. Synergistic action of apoptosis induced by eicosapentaenoic acid and TNP-470 on human breast cancer cells